$ATER
Aterian, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020024353 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $25.63M $17.85M
YoY Change 43.57% 24.65%
Cost Of Revenue $15.33M $11.18M
YoY Change 37.18% 3.0%
Gross Profit $10.30M $6.671M
YoY Change 54.37% 92.25%
Gross Profit Margin 40.18% 37.37%
Selling, General & Admin $21.91M $12.64M
YoY Change 73.36% 14.91%
% of Gross Profit 212.79% 189.48%
Research & Development $2.280M $1.160M
YoY Change 96.55% 3.57%
% of Gross Profit 22.14% 17.39%
Depreciation & Amortization $40.00K $60.00K
YoY Change -33.33% -14.29%
% of Gross Profit 0.39% 0.9%
Operating Expenses $24.19M $13.80M
YoY Change 75.28% 13.89%
Operating Profit -$13.90M -$7.132M
YoY Change 94.84% -17.55%
Interest Expense $1.133M $1.213M
YoY Change -6.6% -316.61%
% of Operating Profit
Other Income/Expense, Net -$25.00K -$45.00K
YoY Change -44.44% -212.5%
Pretax Income -$15.03M -$8.389M
YoY Change 79.16% -8.52%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$15.03M -$8.389M
YoY Change 79.16% -8.52%
Net Earnings / Revenue -58.65% -47.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$989.5K -$485.8K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.10M $13.00M
YoY Change 8.46%
Cash & Equivalents $14.05M $12.97M
Short-Term Investments
Other Short-Term Assets $4.800M $5.000M
YoY Change -4.0%
Inventory $44.30M $33.90M
Prepaid Expenses
Receivables $4.200M $2.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $67.30M $53.90M
YoY Change 24.86%
LONG-TERM ASSETS
Property, Plant & Equipment $200.0K $200.0K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $300.0K
YoY Change -33.33%
Total Long-Term Assets $1.400M $500.0K
YoY Change 180.0%
TOTAL ASSETS
Total Short-Term Assets $67.30M $53.90M
Total Long-Term Assets $1.400M $500.0K
Total Assets $68.70M $54.40M
YoY Change 26.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.70M $13.90M
YoY Change 56.12%
Accrued Expenses $6.000M $8.500M
YoY Change -29.41%
Deferred Revenue
YoY Change
Short-Term Debt $23.90M $20.10M
YoY Change 18.91%
Long-Term Debt Due $4.500M
YoY Change
Total Short-Term Liabilities $56.60M $42.80M
YoY Change 32.24%
LONG-TERM LIABILITIES
Long-Term Debt $9.100M $13.10M
YoY Change -30.53%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $9.100M $13.10M
YoY Change -30.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.60M $42.80M
Total Long-Term Liabilities $9.100M $13.10M
Total Liabilities $65.70M $55.90M
YoY Change 17.53%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.995M -$1.495M
YoY Change
Total Liabilities & Shareholders Equity $68.70M $54.40M
YoY Change 26.29%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$15.03M -$8.389M
YoY Change 79.16% -8.52%
Depreciation, Depletion And Amortization $40.00K $60.00K
YoY Change -33.33% -14.29%
Cash From Operating Activities -$17.09M -$11.92M
YoY Change 43.34% 22.41%
INVESTING ACTIVITIES
Capital Expenditures $18.00K $13.00K
YoY Change 38.46%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$18.00K -$10.00K
YoY Change 80.0% -150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 803.0K 4.627M
YoY Change -82.65% -37.13%
NET CHANGE
Cash From Operating Activities -17.09M -11.92M
Cash From Investing Activities -18.00K -10.00K
Cash From Financing Activities 803.0K 4.627M
Net Change In Cash -16.30M -7.305M
YoY Change 123.18% 209.53%
FREE CASH FLOW
Cash From Operating Activities -$17.09M -$11.92M
Capital Expenditures $18.00K $13.00K
Free Cash Flow -$17.11M -$11.94M
YoY Change 43.34% 22.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11175000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15330000
CY2019Q1 us-gaap Gross Profit
GrossProfit
6671000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10298000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13910000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3366000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
13803000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
24194000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7132000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13896000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1212000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1109000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8389000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15030000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-8389000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-15030000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.99
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11534190
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15193647
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
25000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
25000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8364000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15032000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5369000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1500000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-1495000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7439000
CY2020Q1 mwk Adjustments To Additional Paid In Capital Shares Of Restricted Common Stock Retired In Connection With Vesting
AdjustmentsToAdditionalPaidInCapitalSharesOfRestrictedCommonStockRetiredInConnectionWithVesting
139000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-8389000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-15030000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
55000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41000
CY2019Q1 mwk Provision For Sales Returns
ProvisionForSalesReturns
-38000
CY2020Q1 mwk Provision For Sales Returns
ProvisionForSalesReturns
84000
CY2019Q1 mwk Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
305000
CY2020Q1 mwk Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
304000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1500000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7439000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-57000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-33000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
585000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3140000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3331000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8044000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-200000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-540000
CY2019Q1 mwk Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
-1697000
CY2020Q1 mwk Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
682000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11923000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17091000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
112000
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19184000
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
17435000
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13664000
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15414000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
44000
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
139000
CY2020Q1 mwk Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
965000
CY2019Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
14000
CY2020Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4627000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
803000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7305000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16303000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20708000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30789000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13403000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14486000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12974000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14050000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
300000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
307000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
129000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
129000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
628000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
759000
CY2019Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
22000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates<font style="font-weight:normal;">&#8212;Preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period covered by the financial statements and accompanying notes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates. </font></p>
CY2020Q1 mwk Seller Note From Acquisition
SellerNoteFromAcquisition
195000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
772000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
856000
CY2019Q1 mwk Line Of Credit Facility And Term Loan Interest Expense
LineOfCreditFacilityAndTermLoanInterestExpense
700000
CY2019Q4 mwk Sales Return Reserve
SalesReturnReserve
456000
CY2020Q1 mwk Sales Return Reserve
SalesReturnReserve
540000
CY2019Q4 mwk Seller Note From Acquisition
SellerNoteFromAcquisition
195000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-54300000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
35100000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
37400000
CY2019Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
0
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
102000000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29370000
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35831000
CY2019Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
6842000
CY2020Q1 us-gaap Other Inventory In Transit
OtherInventoryInTransit
8425000
CY2019Q4 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
4700000
CY2020Q1 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
7000000
CY2019Q4 mwk Prepaid Inventory
PrepaidInventory
2195000
CY2020Q1 mwk Prepaid Inventory
PrepaidInventory
2456000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
307000
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
307000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1967000
CY2020Q1 us-gaap Prepaid Insurance
PrepaidInsurance
964000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
926000
CY2020Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1130000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
300000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
388000
CY2019Q4 mwk Accrual For Insurance Financing Current
AccrualForInsuranceFinancingCurrent
1031000
CY2020Q1 mwk Accrual For Insurance Financing Current
AccrualForInsuranceFinancingCurrent
66000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
400000
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
520000
CY2019Q4 mwk Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
2326000
CY2020Q1 mwk Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
2067000
CY2019Q4 mwk Product Related Accruals
ProductRelatedAccruals
1518000
CY2020Q1 mwk Product Related Accruals
ProductRelatedAccruals
1681000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
507000
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
257000
CY2020Q1 mwk Line Of Credit Facility And Term Loan Interest Expense
LineOfCreditFacilityAndTermLoanInterestExpense
500000
CY2019Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
100000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
200000
CY2019Q1 us-gaap Interest Expense
InterestExpense
1213000
CY2020Q1 us-gaap Interest Expense
InterestExpense
1133000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1862569
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28430
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1834139
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
911251
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1834139
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.09
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.00
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.11
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.85
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.11
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M20D
CY2020Q1 mwk Sharebased Compensation Arrangement By Sharebased Payment Award Options Cancelled Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCancelledWeightedAverageRemainingContractualTerm
P9Y8M26D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M3D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M25D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y6M3D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
99289000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10300000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M3D
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7439000

Files In Submission

Name View Source Status
0001564590-20-024353-index-headers.html Edgar Link pending
0001564590-20-024353-index.html Edgar Link pending
0001564590-20-024353.txt Edgar Link pending
0001564590-20-024353-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mwk-10q_20200331.htm Edgar Link pending
mwk-20200331.xml Edgar Link completed
mwk-20200331.xsd Edgar Link pending
mwk-20200331_cal.xml Edgar Link unprocessable
mwk-20200331_def.xml Edgar Link unprocessable
mwk-20200331_lab.xml Edgar Link unprocessable
mwk-20200331_pre.xml Edgar Link unprocessable
mwk-ex311_8.htm Edgar Link pending
mwk-ex312_7.htm Edgar Link pending
mwk-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending